Galectin Therapeutics (GALT) Equity Ratio (2010 - 2026)
Galectin Therapeutics' quarterly Equity Ratio came in at 8.37 in Q1 2026, up 30.0% year-on-year from 6.44 in Q1 2025, and down 27.86% quarter-over-quarter from 6.55 in Q4 2025.
Galectin Therapeutics has reported Equity Ratio for 17 years, with the latest figure at 8.37 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 30.0% year-over-year to 8.37; the trailing twelve-month figure through Mar 2026 stood at 8.37 (up 30.0% YoY), and the FY2025 full-year result was 6.55, down 9.34% from the prior year.
- Equity Ratio for Q1 2026 stood at 8.37, down from 6.55 in the prior quarter.
- The five-year high for Equity Ratio was 0.24 in Q1 2022, with the low at 11.96 in Q1 2025.
- Average Equity Ratio over 5 years is 4.2, with a median of 2.63 recorded in 2023.
- Year-over-year, Equity Ratio slumped 7563.61% in 2022 and soared 30.0% in 2026.
- Tracing GALT's Equity Ratio over 5 years: stood at 1.59 in 2022, then slumped by 37.89% to 2.2 in 2023, then sank by 172.6% to 5.99 in 2024, then fell by 9.34% to 6.55 in 2025, then declined by 27.86% to 8.37 in 2026.
- The last three Equity Ratio figures came in at 8.37 (Q1 2026), 6.55 (Q4 2025), and 9.74 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.21 |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -8.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.37 |
| Dec 31, 2025 | -6.55 |
| Sep 30, 2025 | -9.74 |
| Jun 30, 2025 | -7.62 |
| Mar 31, 2025 | -11.96 |
| Dec 31, 2024 | -5.99 |
| Sep 30, 2024 | -3.25 |
| Jun 30, 2024 | -3.03 |
| Mar 31, 2024 | -1.71 |
| Dec 31, 2023 | -2.20 |
| Sep 30, 2023 | -2.37 |
| Jun 30, 2023 | -2.63 |
| Mar 31, 2023 | -2.19 |
| Dec 31, 2022 | -1.59 |
| Sep 30, 2022 | -1.34 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.20 |
| Jun 30, 2021 | 0.46 |
| Mar 31, 2021 | 0.72 |
| Dec 31, 2020 | 0.76 |
| Sep 30, 2020 | 0.88 |
| Jun 30, 2020 | 0.85 |
| Mar 31, 2020 | 0.93 |
| Dec 31, 2019 | 0.91 |
| Sep 30, 2019 | 0.94 |
| Jun 30, 2019 | 0.94 |
| Mar 31, 2019 | 0.65 |
| Dec 31, 2018 | 0.57 |
| Sep 30, 2018 | 0.68 |
| Jun 30, 2018 | 0.72 |
| Mar 31, 2018 | 0.19 |
| Dec 31, 2017 | -0.13 |
| Sep 30, 2017 | 0.14 |
| Jun 30, 2017 | 0.44 |
| Mar 31, 2017 | 0.57 |
| Dec 31, 2016 | 0.65 |
| Sep 30, 2016 | 0.64 |
| Jun 30, 2016 | 0.41 |
| Mar 31, 2016 | 0.55 |
| Dec 31, 2015 | 0.68 |
| Sep 30, 2015 | 0.60 |
| Jun 30, 2015 | 0.67 |
| Mar 31, 2015 | 0.73 |
| Dec 31, 2014 | 0.71 |
| Sep 30, 2014 | 0.74 |
| Jun 30, 2014 | 0.74 |
| Mar 31, 2014 | 0.77 |
| Dec 31, 2013 | 0.14 |
| Sep 30, 2013 | 0.13 |
| Jun 30, 2013 | -0.59 |
| Mar 31, 2013 | -0.14 |
| Dec 31, 2012 | 0.12 |
| Sep 30, 2012 | 0.27 |
| Jun 30, 2012 | 0.37 |
| Mar 31, 2012 | 0.44 |
| Dec 31, 2011 | -0.32 |
| Sep 30, 2011 | 0.10 |
| Jun 30, 2011 | 0.11 |
| Dec 31, 2010 | -0.27 |